Abdallah, Abdallah Musa
Ansari, Hifzur Rahman
Shuaib, Muhammad
Doudin, Asmma
Yassine, Hadi M.
Shah, Syed Shahab Ud Din
Mir, Fayaz Ahmad
Emara, Mohamed M.
Elzouki, Abdel-Naser
Cyprian, Farhan S.
Funding for this research was provided by:
Qatar University (QUCG-CMED-21/22-2)
Article History
Received: 11 November 2024
Accepted: 29 May 2025
First Online: 2 July 2025
Declarations
:
: The authors declare no competing interests.
: The studies involving human participants were reviewed and approved by Hamad Medical Corporation and Qatar University. The patients/participants provided their written informed consent to participate in this study. In cases where patients were unable to provide informed consent due to any reason (unconsciousness, their medical condition, ventilatory support), the informed consent for study participation was obtained from their legally authorized representatives. The study protocol received approval from the Institutional Review Boards (IRBs) of HMC (MRC-05-136) and Qatar University (QU-IRB 1418-EA/20), including provisions for deferred consent when appropriate.